retatrutide phase 2 obesity nejm 2023 jastreboff π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No weight loss plateau β curve still descending Among participants 4 to 66
Description
Ive been speaking about this at meetings, he says
Your digestive system is recalibrating to a new pace
doi: 10.1016/j.jaci.2009.05.016
Editing by Yaffa Fredrick and Robert Eckhart
Retatrutide is administered subcutaneously, meaning into the fat layer just beneath the skin
Palmer explains how mitochondria do far more than produce energythey regulate neurotransmitters, hormones, inflammation, epigenetics, and responses to stress and trauma, offering a unifying framework for depression, bipolar disorder, schizophrenia, and anxiety
